TickerFactsScreenerDevelopers

Kiniksa Pharmaceuticals International, plc (KNSA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: -$25.73M2017: -$89.71M2018: $279.27M2019: $225.42M2020: $311.94M2021: $185.04M2022: $396.15M2023: $438.84M2024: $438.44M2025: $567.61M$567.61M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$567.61M+29.5%
2024$438.44M-0.1%
2023$438.84M+10.8%
2022$396.15M+114.1%
2021$185.04M-40.7%
2020$311.94M+38.4%
2019$225.42M-19.3%
2018$279.27M+411.3%
2017-$89.71M-248.6%
2016-$25.73M—